The Trump administration’s budget request for fiscal year 2020 (FY20) includes cuts that—if enacted—would hamstring the research and development (R&D) of new global health technologies. Since the release of the budget request in early March, however, lawmakers from both parties have expressed their commitment to shielding critical funding strings from the president’s scissors.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

What global health R&D advocates need to know about the 2018 omnibus spending bill.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.

What global health R&D advocates need to know about the FY2017 budget agreement.

What global health advocates need to know about the President's "skinny" budget.

As the DC summer kicks into full swing, Congress has had a busy month moving forward fiscal year (FY) 2015 funding legislation for a variety of government programs including global health research and development (R&D).

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

As more detailed information about the President’s fiscal year (FY) 2015 budget requests to Congress is released, the results continue to be a mixed bag for global health research and development (R&D).

Yesterday, the White House released President Obama’s much-anticipated budget request for fiscal year (FY) 2015.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

In an increasingly rare show of bipartisanship, Congress has moved forward an appropriations agreement that should finally settle the issue of fiscal year (FY) 2014 funding levels.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

In this guest post, Dr. Beth P. Bell, director of the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) at the Centers for Disease Control and Prevention (CDC), describes some of her center’s active engagement in global health work.

Wednesday, the White House released President Obama’s fiscal year (FY) 2014 budget request, which overall has mixed results for global health and research programs.

In this feature on Breakthroughs, we provide an update on what’s currently happening with global health in Congress and an outlook for future legislative activity.

For those in the global health world—and there are many in the nation’s capital—one common question is why in tight budgetary times should Congress support spending on research and development (R&D) to fight diseases around the world.